Data4Cure

Tweets by Data4Cure mostly on #PrecisionMedicine and #Genomics. We develop the #BiomedicalIntelligence Cloud. Let's turn #data into #cures.

[Data4Cure @Data4Cure]

Mapping pathways of #immunotherapy #resistance for #biomarker development with @Data4Cure Biomedical Intelligence Cloud @jdutkowski at AI in Clinical Trials session #PMWC19

[Data4Cure @Data4Cure]

We are at #AACR2023 today presenting our large scale integration and analysis of scRNA-seq data related to #immunotherapy response

LB176: Interrogating the single cell immune checkpoint inhibition atlas to decipher ICI response mechanisms

https://t.co/3yrqJ8i9v9

[Data4Cure @Data4Cure]

Meet us at the Precision Medicine World Conference #PMWC23 this week!
#KnowledgeGraphs #AI #TranslationalResearch #DrugDiscovery

[Data4Cure @Data4Cure]

Janusz Dutkowski is speaking at #PMWC23 on January 27 at the Santa Clara Convention Center. He will be discussing exciting updates to Data4Cure's Biomedical Intelligence Cloud and its Knowledge Graph Ecosystem #knowledgegraphs #translationalresearch #drugdiscovery.

[Data4Cure @Data4Cure]

Thank you to the speakers in our session: Pallavi Sachdev @PSachdev0802 and Paul Rejto and thanks to Tal Bahar and @PMWCintl team for a great conference!

[Data4Cure @Data4Cure]

See how Data4Cure and partners use #SemanticKnowledgeGraphs in pharmaceutical R&D and clinical trials. #PMWC20 https://t.co/SGsvovPbl1

[Data4Cure @Data4Cure]

Join our speakers Jan 22, 4:45 pm, and come meet us at Booth #1304! @pmwcintl

[Data4Cure @Data4Cure]

Excited to host a session on Semantic AI In Drug Discovery and Clinical Trials at #PMWC20.

[Data4Cure @Data4Cure]

Janusz Dutkowski, PhD, Co-founder & CEO, Data4Cure, will be joined by Pallavi Sachdev, MPH, PhD, Director, Oncology Biomarker Research, @Eisai, and Paul Rejto, PhD, VP, Oncology Translational Research, @Pfizer.

[Data4Cure @Data4Cure]

From #data to #knowledge in biomedicine using semantic #AI. Data4Cure's @jdutkowski in DIA Global Forum @DrugInfoAssn

https://t.co/DJXFGtzYpv

[Dan Chen @DanChenMDPhD]

A critical step forward in the battle against breast cancer. The first cancer immunotherapy regimen approved- specifically in the patients whom benefit most. But breast cancer is a immunologically complex disease- and more advances are needed to help the rest. #immunotherapy

[Data4Cure @Data4Cure]

It was wonderful meeting everyone at #PMWC19! Our team at @Data4Cure had a great conference. Thanks to everyone who visited our booth and attended our talk. Looking forward to collaborating and #TurningDataIntoCures! @cvonraesfeld @roy_ronen @cdeboever3 @jdutkowski

[Data4Cure @Data4Cure]

@CancerLaughs tweet was about mechanisms controlling each stage: activate and recruit turns out to be harder to do than the kill

[Data4Cure @Data4Cure]

Immune desert and immune excluded phenotypes controlled by more complex mechanisms than the inflamed phenotype. ⁦@DanChenMDPhD⁩ #pmwc2019 #cancer #immunotherapy

[@[email protected] @cdeboever3]

@Data4Cure CEO @jdutkowski kicking off session on AI-driven Clinical Trial Design and Patient Selection at #PMWC19 #PMWC2019

[@[email protected] @cdeboever3]

@jdutkowski @Data4Cure platform uses #AI / #MachineLearning approach to identify model of response in IMvigor210 that combines genomic, pathologic, and clinical features. Identifies Wnt signaling pathway as feature, would’ve been missed in univariate analysis #PMWC19 #PMWC2019

[@[email protected] @cdeboever3]

@jdutkowski @Data4Cure #AI / #MachineLearning method for assigning clinical trials into cancer subtypes – identifies novel association between subtype from prior dataset and complete responders in IMvigor210 #PMWC19 #PMWC2019

[Data4Cure @Data4Cure]

Excited to announce that @Data4Cure's @jdutkowski will be speaking and chairing a session on #AI and #MachineLearning in #ClinicalTrials at the upcoming #PMWC19, Jan 21 at the Santa Clara Convention Center! Hope to see you there!

[Data4Cure @Data4Cure]

Chris DeBoever @cdeboever3, VP Platform @Data4Cure exploring the medical phenotype at #ASHG18

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2018 #NobelPrize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”